Entourage Health Reports Second Quarter 2023 Financial Results
TORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and six months ended June 30, 2023. The Company reported second quarter total revenue of $13.37 million and net revenue of $10.17 million, a total revenue increase of 1% and net revenue increase of 5%, showing consistent year-over-year performance. The Company will host a conference call to discuss its financial and business highlights on Wednesday, August 30, 2023, at 10 a.m. Eastern Time.
Related news for (ETRGF)
- Entourage Health Corp. Announces Closing of Plan of Arrangement
- Entourage Health Increases Senior Secured Credit Facility
- Entourage Health Corp. Announces Shareholder Approval of Going-Private Transaction
- Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
- Entourage Health Reports Strong Third Quarter 2024 Financial Results